Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast

In recent years, the concept of synthetic lethality, describing a cellular state where loss of two genes leads to a non-viable phenotype while loss of one gene can be compensated, has emerged as a novel strategy for cancer therapy. Various compounds targeting synthetic lethal pathways are either und...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Marhold, Maximilian, Tomasich, Erwin, Schwarz, Michael, Udovica, Simon, Heinzel, Andreas, Mayer, Paul, Horak, Peter, Perco, Paul, Krainer, Michael
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2018
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6284748/
https://ncbi.nlm.nih.gov/pubmed/30555636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26372
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg